Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,700
Avg Vol 394
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 98%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 353 1 817 0370
Address:
Riverside II, Sir John Rogerson’s Quay, Dublin, Ireland
Latest News on CMOPF
No data available.